Peter T.W. CHENG,Wei Meng,Mark Liu,Bei Wang,Rulin Zhao
申请号：
US16318173
公开号：
US20190233449A1
申请日:
2017.07.21
申请国别(地区):
US
年份:
2019
代理人:
摘要：
A compound, enantiomer, prodrug, diastereomer, or salt is provided which is an activator of the enzyme glucokinase and thus is believed to be useful in as treating diabetes and related diseases, which compound has the structure (I). A method for treating diabetes and related disease employing the compound, enantiomer, prodrug, diastereomer, or salt is also provided.
